Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

[Regulation of cholesterol metabolism is neuroprotective in Huntington's disease].

Caboche J, Kacher R, Betuing S.

Med Sci (Paris). 2020 Jan;36(1):12-15. doi: 10.1051/medsci/2019253. Epub 2020 Feb 4. French. No abstract available.

PMID:
32014090
2.

From Signaling Molecules to Circuits and Behaviors: Cell-Type-Specific Adaptations to Psychostimulant Exposure in the Striatum.

Salery M, Trifilieff P, Caboche J, Vanhoutte P.

Biol Psychiatry. 2019 Nov 9. pii: S0006-3223(19)31849-9. doi: 10.1016/j.biopsych.2019.11.001. [Epub ahead of print] Review.

3.

Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease.

Yildirim F, Ng CW, Kappes V, Ehrenberger T, Rigby SK, Stivanello V, Gipson TA, Soltis AR, Vanhoutte P, Caboche J, Housman DE, Fraenkel E.

Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24840-24851. doi: 10.1073/pnas.1908113116. Epub 2019 Nov 19.

PMID:
31744868
4.

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.

Kacher R, Lamazière A, Heck N, Kappes V, Mounier C, Despres G, Dembitskaya Y, Perrin E, Christaller W, Sasidharan Nair S, Messent V, Cartier N, Vanhoutte P, Venance L, Saudou F, Néri C, Caboche J, Betuing S.

Brain. 2019 Aug 1;142(8):2432-2450. doi: 10.1093/brain/awz174.

PMID:
31286142
5.

CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.

Boussicault L, Kacher R, Lamazière A, Vanhoutte P, Caboche J, Betuing S, Potier MC.

Biochimie. 2018 Oct;153:70-79. doi: 10.1016/j.biochi.2018.07.019. Epub 2018 Aug 11.

PMID:
30107216
6.

Antidepressive effects of targeting ELK-1 signal transduction.

Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JP, Grenier J, Ibrahim EC, El Khoury MA, Tse YC, Mongredien R, Barbé A, de Macedo CEA, Jaworski W, Bochereau A, Orrico A, Isingrini E, Guinaudie C, Mikasova L, Louis F, Gautron S, Groc L, Massaad C, Yildirim F, Vialou V, Dumas S, Marti F, Mechawar N, Morice E, Wong TP, Caboche J, Turecki G, Giros B, Tzavara ET.

Nat Med. 2018 May;24(5):591-597. doi: 10.1038/s41591-018-0011-0. Epub 2018 May 7.

PMID:
29736027
7.

Serotonergic Signaling Controls Input-Specific Synaptic Plasticity at Striatal Circuits.

Cavaccini A, Gritti M, Giorgi A, Locarno A, Heck N, Migliarini S, Bertero A, Mereu M, Margiani G, Trusel M, Catelani T, Marotta R, De Luca MA, Caboche J, Gozzi A, Pasqualetti M, Tonini R.

Neuron. 2018 May 16;98(4):801-816.e7. doi: 10.1016/j.neuron.2018.04.008. Epub 2018 Apr 26.

8.

Cocaine conditioned place preference: unexpected suppression of preference due to testing combined with strong conditioning.

Marion-Poll L, Besnard A, Longueville S, Valjent E, Engmann O, Caboche J, Hervé D, Girault JA.

Addict Biol. 2019 May;24(3):364-375. doi: 10.1111/adb.12600. Epub 2018 Jan 10.

PMID:
29318708
9.

Cocaine increases dopaminergic connectivity in the nucleus accumbens.

Dos Santos M, Cahill EN, Bo GD, Vanhoutte P, Caboche J, Giros B, Heck N.

Brain Struct Funct. 2018 Mar;223(2):913-923. doi: 10.1007/s00429-017-1532-x. Epub 2017 Oct 12.

PMID:
29027032
10.

Rapid Synaptogenesis in the Nucleus Accumbens Is Induced by a Single Cocaine Administration and Stabilized by Mitogen-Activated Protein Kinase Interacting Kinase-1 Activity.

Dos Santos M, Salery M, Forget B, Garcia Perez MA, Betuing S, Boudier T, Vanhoutte P, Caboche J, Heck N.

Biol Psychiatry. 2017 Dec 1;82(11):806-818. doi: 10.1016/j.biopsych.2017.03.014. Epub 2017 Mar 29.

11.

Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin.

Galan-Rodriguez B, Martin E, Brouillet E, Déglon N, Betuing S, Caboche J.

Eur J Neurosci. 2017 Jan;45(1):198-206. doi: 10.1111/ejn.13415. Epub 2016 Oct 24.

PMID:
27717053
12.

Activity-Regulated Cytoskeleton-Associated Protein Accumulates in the Nucleus in Response to Cocaine and Acts as a Brake on Chromatin Remodeling and Long-Term Behavioral Alterations.

Salery M, Dos Santos M, Saint-Jour E, Moumné L, Pagès C, Kappès V, Parnaudeau S, Caboche J, Vanhoutte P.

Biol Psychiatry. 2017 Apr 1;81(7):573-584. doi: 10.1016/j.biopsych.2016.05.025. Epub 2016 Jun 16.

13.

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

Boussicault L, Alves S, Lamazière A, Planques A, Heck N, Moumné L, Despres G, Bolte S, Hu A, Pagès C, Galvan L, Piguet F, Aubourg P, Cartier N, Caboche J, Betuing S.

Brain. 2016 Mar;139(Pt 3):953-70. doi: 10.1093/brain/awv384. Epub 2016 Jan 29.

14.

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.

Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N, Herzog E, Bolte S, Prado VF, Prado MA, Bellivier F, Eap CB, Crettol S, Vanhoutte P, Caboche J, Gratton A, Moquin L, Giros B, Maldonado R, Daumas S, Mameli M, Jamain S, El Mestikawy S.

Mol Psychiatry. 2015 Nov;20(11):1448-59. doi: 10.1038/mp.2015.104. Epub 2015 Aug 4.

PMID:
26239290
15.

Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism.

Södersten E, Feyder M, Lerdrup M, Gomes AL, Kryh H, Spigolon G, Caboche J, Fisone G, Hansen K.

PLoS Genet. 2014 Sep 25;10(9):e1004574. doi: 10.1371/journal.pgen.1004574. eCollection 2014 Sep.

16.

A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression.

Feyder M, Södersten E, Santini E, Vialou V, LaPlant Q, Watts EL, Spigolon G, Hansen K, Caboche J, Nestler EJ, Fisone G.

Biol Psychiatry. 2016 Mar 1;79(5):362-371. doi: 10.1016/j.biopsych.2014.07.019. Epub 2014 Jul 28.

17.

D1R/GluN1 complexes in the striatum integrate dopamine and glutamate signalling to control synaptic plasticity and cocaine-induced responses.

Cahill E, Pascoli V, Trifilieff P, Savoldi D, Kappès V, Lüscher C, Caboche J, Vanhoutte P.

Mol Psychiatry. 2014 Dec;19(12):1295-304. doi: 10.1038/mp.2014.73. Epub 2014 Jul 29.

18.

A new automated 3D detection of synaptic contacts reveals the formation of cortico-striatal synapses upon cocaine treatment in vivo.

Heck N, Dos Santos M, Amairi B, Salery M, Besnard A, Herzog E, Boudier T, Vanhoutte P, Caboche J.

Brain Struct Funct. 2015 Sep;220(5):2953-66. doi: 10.1007/s00429-014-0837-2. Epub 2014 Jul 8.

PMID:
25001083
19.

Extracellular signal-regulated protein kinases 1 and 2 activation by addictive drugs: a signal toward pathological adaptation.

Pascoli V, Cahill E, Bellivier F, Caboche J, Vanhoutte P.

Biol Psychiatry. 2014 Dec 15;76(12):917-26. doi: 10.1016/j.biopsych.2014.04.005. Epub 2014 Apr 18. Review.

PMID:
24844603
20.

The transcription factor Zif268/Egr1, brain plasticity, and memory.

Veyrac A, Besnard A, Caboche J, Davis S, Laroche S.

Prog Mol Biol Transl Sci. 2014;122:89-129. doi: 10.1016/B978-0-12-420170-5.00004-0. Review.

PMID:
24484699
21.

Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse.

Cahill E, Salery M, Vanhoutte P, Caboche J.

Front Pharmacol. 2014 Jan 8;4:172. doi: 10.3389/fphar.2013.00172. Review.

22.

Multiple Aspects of Gene Dysregulation in Huntington's Disease.

Moumné L, Betuing S, Caboche J.

Front Neurol. 2013 Oct 23;4:127. doi: 10.3389/fneur.2013.00127. Review.

23.

Recall and reconsolidation of contextual fear memory: differential control by ERK and Zif268 expression dosage.

Besnard A, Caboche J, Laroche S.

PLoS One. 2013 Aug 16;8(8):e72006. doi: 10.1371/journal.pone.0072006. eCollection 2013.

24.

Comparative dynamics of MAPK/ERK signalling components and immediate early genes in the hippocampus and amygdala following contextual fear conditioning and retrieval.

Besnard A, Laroche S, Caboche J.

Brain Struct Funct. 2014 Jan;219(1):415-30. doi: 10.1007/s00429-013-0505-y. Epub 2013 Feb 7. Erratum in: Brain Struct Funct. 2014 Jan;219(1):431.

PMID:
23389809
25.

Reconsolidation of memory: a decade of debate.

Besnard A, Caboche J, Laroche S.

Prog Neurobiol. 2012 Oct;99(1):61-80. doi: 10.1016/j.pneurobio.2012.07.002. Epub 2012 Aug 7. Review.

PMID:
22877586
26.

Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement.

Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S, Baudonnat M, Husson M, Besson M, Reperant C, Zemdegs J, Pagès C, Hay YA, Lambolez B, Caboche J, Gutkin B, Gardier AM, Changeux JP, Faure P, Maskos U.

Mol Psychiatry. 2013 Mar;18(3):382-93. doi: 10.1038/mp.2012.83. Epub 2012 Jul 3.

PMID:
22751493
27.

In vivo validation of the unified BARGE method to assess the bioaccessibility of arsenic, antimony, cadmium, and lead in soils.

Denys S, Caboche J, Tack K, Rychen G, Wragg J, Cave M, Jondreville C, Feidt C.

Environ Sci Technol. 2012 Jun 5;46(11):6252-60. doi: 10.1021/es3006942. Epub 2012 May 24.

PMID:
22606949
28.

Huntington's Disease and Striatal Signaling.

Roze E, Cahill E, Martin E, Bonnet C, Vanhoutte P, Betuing S, Caboche J.

Front Neuroanat. 2011 Aug 23;5:55. doi: 10.3389/fnana.2011.00055. eCollection 2011.

29.

Alterations of molecular and behavioral responses to cocaine by selective inhibition of Elk-1 phosphorylation.

Besnard A, Bouveyron N, Kappes V, Pascoli V, Pagès C, Heck N, Vanhoutte P, Caboche J.

J Neurosci. 2011 Oct 5;31(40):14296-307. doi: 10.1523/JNEUROSCI.2890-11.2011.

30.

Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers.

Peyrin JM, Deleglise B, Saias L, Vignes M, Gougis P, Magnifico S, Betuing S, Pietri M, Caboche J, Vanhoutte P, Viovy JL, Brugg B.

Lab Chip. 2011 Nov 7;11(21):3663-73. doi: 10.1039/c1lc20014c. Epub 2011 Sep 15.

PMID:
21922081
31.

A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington's disease.

Heck N, Betuing S, Vanhoutte P, Caboche J.

Brain Struct Funct. 2012 Apr;217(2):421-34. doi: 10.1007/s00429-011-0340-y. Epub 2011 Aug 6.

PMID:
21822732
32.

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter.

Martin E, Betuing S, Pagès C, Cambon K, Auregan G, Deglon N, Roze E, Caboche J.

Hum Mol Genet. 2011 Jun 15;20(12):2422-34. doi: 10.1093/hmg/ddr148. Epub 2011 Apr 14.

33.

Elk-1 a transcription factor with multiple facets in the brain.

Besnard A, Galan-Rodriguez B, Vanhoutte P, Caboche J.

Front Neurosci. 2011 Mar 16;5:35. doi: 10.3389/fnins.2011.00035. eCollection 2011.

34.

Implication of CCR2 chemokine receptor in cocaine-induced sensitization.

Trocello JM, Rostene W, Melik-Parsadaniantz S, Godefroy D, Roze E, Kitabgi P, Kuziel WA, Chalon S, Caboche J, Apartis E.

J Mol Neurosci. 2011 Jul;44(3):147-51. doi: 10.1007/s12031-011-9508-4. Epub 2011 Mar 22.

PMID:
21424761
35.

Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation.

Pascoli V, Besnard A, Hervé D, Pagès C, Heck N, Girault JA, Caboche J, Vanhoutte P.

Biol Psychiatry. 2011 Feb 1;69(3):218-27. doi: 10.1016/j.biopsych.2010.08.031. Epub 2010 Nov 4.

PMID:
21055728
36.

Huntington's disease.

Roze E, Bonnet C, Betuing S, Caboche J.

Adv Exp Med Biol. 2010;685:45-63. Review.

PMID:
20687494
37.

Modelling Pb bioaccessibility in soils contaminated by mining and smelting activities.

Caboche J, Denys S, Feidt C, Delalain P, Tack K, Rychen G.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2010 Aug;45(10):1264-74. doi: 10.1080/10934529.2010.493818.

PMID:
20635294
38.

Cellular mechanisms of long-term depression induced by noradrenaline in rat prefrontal neurons.

Marzo A, Bai J, Caboche J, Vanhoutte P, Otani S.

Neuroscience. 2010 Aug 11;169(1):74-86. doi: 10.1016/j.neuroscience.2010.04.046. Epub 2010 Apr 29.

PMID:
20434527
39.

Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation.

Deyts C, Galan-Rodriguez B, Martin E, Bouveyron N, Roze E, Charvin D, Caboche J, Bétuing S.

PLoS One. 2009 Dec 15;4(12):e8287. doi: 10.1371/journal.pone.0008287.

40.

Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) controls activation of extracellular signal-regulated kinase (ERK) signaling in the striatum and long-term behavioral responses to cocaine.

Fasano S, D'Antoni A, Orban PC, Valjent E, Putignano E, Vara H, Pizzorusso T, Giustetto M, Yoon B, Soloway P, Maldonado R, Caboche J, Brambilla R.

Biol Psychiatry. 2009 Oct 15;66(8):758-68. doi: 10.1016/j.biopsych.2009.03.014. Epub 2009 May 15.

41.

Endocytosis controls glutamate-induced nuclear accumulation of ERK.

Trifilieff P, Lavaur J, Pascoli V, Kappès V, Brami-Cherrier K, Pagès C, Micheau J, Caboche J, Vanhoutte P.

Mol Cell Neurosci. 2009 Jul;41(3):325-36. doi: 10.1016/j.mcn.2009.04.006. Epub 2009 May 3.

PMID:
19398002
42.

Background dopamine concentration dependently facilitates long-term potentiation in rat prefrontal cortex through postsynaptic activation of extracellular signal-regulated kinases.

Kolomiets B, Marzo A, Caboche J, Vanhoutte P, Otani S.

Cereb Cortex. 2009 Nov;19(11):2708-18. doi: 10.1093/cercor/bhp047. Epub 2009 Mar 12.

PMID:
19282455
43.

Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse.

Brami-Cherrier K, Roze E, Girault JA, Betuing S, Caboche J.

J Neurochem. 2009 Mar;108(6):1323-35. doi: 10.1111/j.1471-4159.2009.05879.x. Epub 2009 Jan 12. Review. Erratum in: J Neurochem. 2009 Jul;10(1):422.

44.

Bioaccessibility, solid phase distribution, and speciation of Sb in soils and in digestive fluids.

Denys S, Tack K, Caboche J, Delalain P.

Chemosphere. 2009 Feb;74(5):711-6. doi: 10.1016/j.chemosphere.2008.09.088. Epub 2008 Nov 22.

PMID:
19027930
45.

[Pathophysiology of Huntington's disease: an update].

Roze E, Betuing S, Deyts C, Vidailhet M, Caboche J.

Rev Neurol (Paris). 2008 Dec;164(12):977-94. doi: 10.1016/j.neurol.2008.03.006. Epub 2008 May 13. Review. French.

PMID:
18808762
46.

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.

Roze E, Saudou F, Caboche J.

Curr Opin Neurol. 2008 Aug;21(4):497-503. doi: 10.1097/WCO.0b013e328304b692. Review.

PMID:
18607213
47.

Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models.

Brochier C, Gaillard MC, Diguet E, Caudy N, Dossat C, Ségurens B, Wincker P, Roze E, Caboche J, Hantraye P, Brouillet E, Elalouf JM, de Chaldée M.

Physiol Genomics. 2008 Apr 22;33(2):170-9. doi: 10.1152/physiolgenomics.00125.2007. Epub 2008 Feb 5.

PMID:
18252803
48.

A TAT-DEF-Elk-1 peptide regulates the cytonuclear trafficking of Elk-1 and controls cytoskeleton dynamics.

Lavaur J, Bernard F, Trifilieff P, Pascoli V, Kappes V, Pagès C, Vanhoutte P, Caboche J.

J Neurosci. 2007 Dec 26;27(52):14448-58.

49.

Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.

Roze E, Betuing S, Deyts C, Marcon E, Brami-Cherrier K, Pagès C, Humbert S, Mérienne K, Caboche J.

FASEB J. 2008 Apr;22(4):1083-93. Epub 2007 Nov 20.

PMID:
18029446
50.

Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo.

Charvin D, Roze E, Perrin V, Deyts C, Betuing S, Pagès C, Régulier E, Luthi-Carter R, Brouillet E, Déglon N, Caboche J.

Neurobiol Dis. 2008 Jan;29(1):22-9. Epub 2007 Aug 19.

PMID:
17905594

Supplemental Content

Loading ...
Support Center